E2F3 was generally considered to increase cellular proliferation as a transcriptional activator through promoting the G1/S transition and its amplification was strongly associated with invasive tumor phenotype and high tumor grade in a subset of bladder tumors and prostate cancer [15, 22]. The gene discussed is E2F3; the disease is neoplasm.